William Hrushesky to Middle Aged
This is a "connection" page, showing publications William Hrushesky has written about Middle Aged.
Connection Strength
0.431
-
The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 2011 May 23; 11:193.
Score: 0.027
-
Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology. 2010 Feb; 19(2):180-9.
Score: 0.025
-
Circadian disruption, Per3, and human cytokine secretion. Integr Cancer Ther. 2009 Dec; 8(4):329-36.
Score: 0.024
-
Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst. 2007 Jul 04; 99(13):1053; author reply 1053-4.
Score: 0.021
-
Enhanced surgery-induced angiogenesis among premenopausal women might partially explain excess breast cancer mortality of blacks compared to whites: an hypothesis. Int J Surg. 2007 Oct; 5(5):300-4.
Score: 0.020
-
Screening and breast cancer. N Engl J Med. 2006 Feb 16; 354(7):767-9; author reply 767-9.
Score: 0.019
-
Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer. 2005 Nov 28; 93(11):1202-8.
Score: 0.018
-
Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther. 2003 Jun; 2(2):105-11.
Score: 0.016
-
Breast cancer screening: controversies and future directions. Curr Opin Obstet Gynecol. 2003 Feb; 15(1):1-8.
Score: 0.015
-
Breast cancer screening for women aged 40-49 years: screening may not be the benign process usually thought. J Natl Cancer Inst. 2001 Oct 17; 93(20):1572.
Score: 0.014
-
Wounding from biopsy and breast-cancer progression. Lancet. 2001 Mar 31; 357(9261):1048.
Score: 0.013
-
Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat. 2001 Feb; 65(3):217-24.
Score: 0.013
-
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PLoS One. 2020; 15(6):e0234541.
Score: 0.013
-
Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):873-81.
Score: 0.012
-
Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation. J Natl Cancer Inst. 1998 Oct 07; 90(19):1480-4.
Score: 0.011
-
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 06; 13(6):e562-e573.
Score: 0.010
-
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia. Br J Haematol. 2018 01; 180(2):301-304.
Score: 0.010
-
Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest. 1995 Apr; 95(4):1650-9.
Score: 0.009
-
Diminishment of respiratory sinus arrhythmia foreshadows doxorubicin-induced cardiomyopathy. Circulation. 1991 Aug; 84(2):697-707.
Score: 0.007
-
Quantitative respiratory sinus arrhythmia analysis. A simple noninvasive, reimbursable measure of cardiac wellness and dysfunction. Ann N Y Acad Sci. 1991; 618:67-101.
Score: 0.007
-
Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. BMC Cancer. 2010 Nov 30; 10:656.
Score: 0.007
-
Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. J Clin Oncol. 1990 Sep; 8(9):1504-13.
Score: 0.006
-
Oral temperature rhythmometry and substantial within-day variation in zidovudine levels following steady-state dosing in human immunodeficiency virus (HIV) infection. Prog Clin Biol Res. 1990; 341A:67-76.
Score: 0.006
-
Menstrual history and breast cancer surgery. Breast Cancer Res Treat. 1989 Jul; 13(3):278.
Score: 0.006
-
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS. 2008 Jul-Aug; 116(7-8):730-41.
Score: 0.006
-
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer. Clin Colorectal Cancer. 2008 Mar; 7(2):134-9.
Score: 0.005
-
Progressive metastatic renal cell carcinoma controlled by continuous 5-fluoro-2-deoxyuridine infusion. J Urol. 1988 Feb; 139(2):259-62.
Score: 0.005
-
Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma. Semin Surg Oncol. 1988; 4(2):110-5.
Score: 0.005
-
High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer. Cancer Treat Rep. 1987 Oct; 71(10):915-9.
Score: 0.005
-
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):852-7.
Score: 0.005
-
High-dose intensity systemic therapy of metastatic bladder cancer. J Clin Oncol. 1987 Mar; 5(3):450-5.
Score: 0.005
-
Advanced transitional cell bladder cancer: a treatable disease. Semin Surg Oncol. 1986; 2(2):76-89.
Score: 0.005
-
Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol Int. 1986; 3(1):55-64.
Score: 0.005
-
Lack of antiemetic effect of high-dose metoclopramide. J Clin Oncol. 1985 Sep; 3(9):1273-6.
Score: 0.005
-
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005 Jan; 41(1):88-96.
Score: 0.004
-
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour. Breast Cancer Res. 2004; 6(6):R689-96.
Score: 0.004
-
24-hour mean pulse. Simple predictor of doxorubicin-induced cardiac damage. Am J Med. 1984 Sep; 77(3):399-406.
Score: 0.004
-
The respiratory sinus arrhythmia: a measure of cardiac age. Science. 1984 Jun 01; 224(4652):1001-4.
Score: 0.004
-
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res. 2004; 6(4):R372-4.
Score: 0.004
-
Lack of age-dependent cisplatin nephrotoxicity. Am J Med. 1984 Apr; 76(4):579-84.
Score: 0.004
-
Circadian mesor of recumbent pulse--cost-effective predictor of doxorubicin-induced congestive heart failure. Chronobiol Int. 1984; 1(1):59-66.
Score: 0.004
-
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. J Clin Oncol. 2004 Jan 01; 22(1):102-7.
Score: 0.004
-
The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
Score: 0.004
-
Circadian time dependence of cisplatin urinary kinetics. Clin Pharmacol Ther. 1982 Sep; 32(3):330-9.
Score: 0.004
-
Unusual pigmentary changes associated with 5-fluorouracil therapy. Cutis. 1980 Aug; 26(2):181-82.
Score: 0.003
-
Letter: Serpentine supravenous fluorouracil hyperpigmentation. JAMA. 1976 Jul 12; 236(2):138.
Score: 0.002
-
Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation. Cancer Treat Rep. 1976 May; 60(5):639.
Score: 0.002
-
Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases. Cancer. 1995 May 15; 75(10):2558-64.
Score: 0.002
-
[Biological rhythms and tumor markers in man. With special reference to the carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in digestive system tumors]. Acta Gastroenterol Belg. 1987 Jan-Feb; 50(1):12-21.
Score: 0.001